Tuberculosis (TB)
37
15
16
12
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 37 trials
100.0%
+13.5% vs benchmark
11%
4 trials in Phase 3/4
0%
0 of 12 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 12 completed trials
Clinical Trials (37)
Tuberculosis in Rural and Malnourished Populations
Integrating HIV Prevention With TB Household Contact Evaluation in Uganda
Safety and Immunogenicity of a Mycobacterium Tuberculosis Vaccine MTBVAC in Healthy Indian Adults and Adolescents (BBV169/2024)
Prevention and Mass Screening of TB in Prisons in Paraguay
A Study to Evaluate the Efficacy, Safety and Immunogenicity of MTBVAC in Adolescents and Adults Living in a TB Endemic Region.
Burden of Tuberculosis Among Pregnant and Postpartum Women in Guinea-Bissau
Questioning the Epidemiology of Asymptomatic TB
Effectiveness of Computer-Aided Detection Chest X-Ray Screening for Improving Tuberculosis Diagnostic Yield in Chinese Primary Health Care Settings: Study Protocol for a Prospective Cluster Randomized Controlled Trial
TB SCReening Improves Preventive Therapy Uptake in Pregnant Women With HIV
Effectiveness of Chat-based Mobile Application for Consultation (Zalo) in Improving Compliance With Follow-up Tests After Abnormal Chest X-ray Findings Interpret by Artificial Intelligent
Respiratory Health and Wellbeing Post Pulmonary Tuberculosis
The Role of Decortication in Complex Empyema Cases: Multidrug Resistance and Tuberculosis at the Forefront
ESAT6/CFP10 Skin Testing for TB Infection in Rheumatologic Patients
Optimal Treatment Duration for Radiographically Apparent, Bacteriologically Unconfirmed TB, Identified Through Active Case Finding (RADIO-TB Trial)
Xpert MTB/RIF Ultra Trial
Tuberculosis (TB) Aftermath
Pharmacist-led Digital Interventions to Improve Tuberculosis Treatment Adherence
Comparison of the Outcome of Treatment With Silymarin or N-Aceylcysteine in Patients Taking Anti-Tuberculous Drugs for Tuberculosis at a Tertiary Care Hospital , Karachi
Cardiometabolic Risk Factors Associated With Multidrug-Resistant Tuberculosis
PRecision biomArker-Guided MAnagement of TuberculosIs Contacts: a Discrete Choice Experiment